Comparing two ways to deliver chemotherapy for advanced stomach cancer with spread to the lining of the abdomen
Treatments studied
Part of Cancer clinical trials.
This study tests a new way to give chemotherapy as a mist directly into the belly during a keyhole surgery for stomach cancer that has spread to the lining of the abdomen. It compares this method to the usual approach to see if it works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have stomach cancer that has spread to the lining of the abdomen, confirmed by tests or surgery, and the cancer is not removable with surgery.
- You are healthy enough for keyhole surgery (special type of laparoscopy).
- Your daily activities are not limited (you can do normal work and activities).
- You have good blood counts, liver and kidney function, and no active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specialized chemotherapy delivery method called PIPAC—where chemotherapy is sprayed directly into the abdomen under pressure—for patients with gastric cancer that has spread to the abdominal lining. The goal is to deliver stronger doses of chemotherapy directly to where the cancer is, potentially helping patients who aren't candidates for major surgery.
This trial studies chemotherapy given before surgery for advanced stomach (gastric) cancer, including treatment when cancer may be on the stomach lining (peritoneum). It may help shrink tumors and improve outcomes for people who meet specific marker and staging requirements.
This trial tests adding the chemotherapy drug paclitaxel directly into the abdomen (intraperitoneal) along with standard IV chemotherapy for people with stomach or gastroesophageal junction cancer that has spread to the lining of the abdomen. The goal is to see if this combination helps control the cancer better than standard treatment alone.
This trial tests a combination of low-dose radiation, chemotherapy, and an immunotherapy drug (AK112) for people with advanced stomach or gastroesophageal junction cancer that has progressed after first-line treatment. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
This study tests whether a thorough surgery to remove stomach cancer in the abdomen, followed by chemotherapy given through the belly and by vein, can improve outcomes. It’s for people newly diagnosed with stomach cancer that has limited spread to the belly lining.
This trial looks at a way to give chemotherapy into the abdomen (through a small tube during laparoscopy) for certain stomach cancers. It aims to see whether this approach improves cancer control and surgical outcomes for people whose tumors can potentially be removed.
Hear when a new Advanced Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.